54
Participants
Start Date
September 4, 2020
Primary Completion Date
November 17, 2023
Study Completion Date
December 31, 2024
Dextenza (IDI) (Sustained Release Dexamethasone), (0.4 mg)
Intracanalicular dexamethasone insert contains 0.4 mg dexamethasone and is designed to provide a sustained and tapered release of therapeutic levels of dexamethasone to the ocular surface for up to 30 days for the reduction of postsurgical inflammation and pain associated with ocular surgery.
ProLong™ collagen plugs
The long term synthetic punctal plug is composed of an absorbable copolymer material and measures 0.4mm in diameter and 2.0mm in length.
Tufts Medical Center, Boston
Collaborators (1)
Ocular Therapeutix, Inc.
INDUSTRY
Tufts Medical Center
OTHER